CD80 and dermatomyositis: In this study, we showed that in vitro, NECA decreased the expression of surface markers CD40 and CD80 in mouse BMDCs and DCs of patients with DM and healthy individuals and the expression of MHCII in BMDCs and HLA-DR in DCs of healthy individuals.